Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Peter M. Fayers |
| Publication date | October 31, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |